- Luminex (NASDAQ:LMNX +1.7%) Q3 results: Revenues: $56.7M (+11.6%); Technology & Strategic Partnerships: $32.6M (-2.1%), Assays & Related Products: $24M (+37.9%), Consumables: $12.1M (-5.5%); COGS: $17.7M (-11.5%); R&D Expense: $10.3M (unch); SG&A: $21.4M (-0.5%); Operating Income: $5M (+219.0%); Net Income: $5.6M (+600.0%); EPS: $0.13 (+550.0%); Quick Assets: $89.1M (+31.2%); CF Ops: $11.5M (+3.6%).
- 2014 Guidance: Revenue: $225M - 228M from $225M - 240M.